Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedUpdated page to version v3.2.0, added operating-status notice and a new resource on Spinal muscular atrophy; removed the old revision v3.1.0 reference.SummaryDifference2%
- Check24 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%
- Check38 days agoChange DetectedThe page updates the revision from v3.0.1 to v3.0.2 and removes the Back to Top element. This does not affect core content or other critical information.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of multiple facility locations across various countries, such as Belgium, Brazil, Italy, Japan, Poland, Russia, Spain, Turkey, and Ukraine. Additionally, a new reference to a pharmacokinetic study has been included, while previous location entries have been removed.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.